Bridgeway Capital Management’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,475
| Closed | -$38.3K | – | 1390 |
|
|
2023
Q2 | $38.3K | Hold |
1,475
| – | – | ﹤0.01% | 1346 |
|
|
2023
Q1 | $37.2K | Hold |
1,475
| – | – | ﹤0.01% | 1331 |
|
|
2022
Q4 | $36.9K | Hold |
1,475
| – | – | ﹤0.01% | 1320 |
|
|
2022
Q3 | $39K | Sell |
1,475
-2,000
| -58% | -$52.9K | ﹤0.01% | 1363 |
|
|
2022
Q2 | $113K | Hold |
3,475
| – | – | ﹤0.01% | 1206 |
|
|
2022
Q1 | $127K | Buy |
+3,475
| New | +$127K | ﹤0.01% | 1239 |
|
|
2021
Q2 | – | Sell |
-253
| Closed | -$217K | – | 1356 |
|
|
2021
Q1 | $217K | Hold |
253
| – | – | ﹤0.01% | 1278 |
|
|
2020
Q4 | $230K | Hold |
253
| – | – | ﹤0.01% | 1179 |
|
|
2020
Q3 | $307K | Buy |
+253
| New | +$307K | 0.01% | 1056 |
|
|
2020
Q2 | – | Sell |
-35
| Closed | -$16K | – | 1329 |
|
|
2020
Q1 | $16K | Hold |
35
| – | – | ﹤0.01% | 1254 |
|
|
2019
Q4 | $7K | Sell |
35
-150
| -81% | -$30K | ﹤0.01% | 1301 |
|
|
2019
Q3 | $46K | Sell |
185
-85
| -31% | -$21.1K | ﹤0.01% | 1277 |
|
|
2019
Q2 | $676K | Sell |
270
-40
| -13% | -$100K | 0.01% | 878 |
|
|
2019
Q1 | $1.26M | Buy |
310
+36
| +13% | +$147K | 0.02% | 677 |
|
|
2018
Q4 | $844K | Hold |
274
| – | – | 0.01% | 796 |
|
|
2018
Q3 | $1.6M | Buy |
274
+7
| +3% | +$41K | 0.02% | 700 |
|
|
2018
Q2 | $934K | Hold |
267
| – | – | 0.01% | 897 |
|
|
2018
Q1 | $1.19M | Hold |
267
| – | – | 0.01% | 793 |
|
|
2017
Q4 | $1.03M | Buy |
+267
| New | +$1.03M | 0.01% | 839 |
|